HomeCVKD • NASDAQ
add
Cadrenal Therapeutics Inc
Previous close
$15.50
Day range
$14.20 - $15.97
Year range
$5.70 - $22.90
Market cap
28.03M USD
Avg Volume
20.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.93M | 123.74% |
Net income | -3.85M | -131.19% |
Net profit margin | — | — |
Earnings per share | -2.09 | -39.33% |
EBITDA | -3.92M | -123.50% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.34M | 11.72% |
Total assets | 7.95M | 12.84% |
Total liabilities | 1.84M | 114.89% |
Total equity | 6.11M | — |
Shares outstanding | 1.97M | — |
Price to book | 4.84 | — |
Return on assets | -108.65% | — |
Return on capital | -144.92% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.85M | -131.19% |
Cash from operations | -4.65M | -153.15% |
Cash from investing | -3.25K | — |
Cash from financing | 1.97M | 661,019.46% |
Net change in cash | -2.68M | -46.06% |
Free cash flow | -3.81M | -199.97% |
About
Founded
2022
Website
Employees
4
